Active
PanTera logo

PanTera

Switched

BE0784992591

Rechtspersoon Public limited company 1 establishment

Boeretang 192, 2400 Mol Vervaardiging van overige farmaceutische producten pantera-life.com

Active for

4 year, 4 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Revenue

€ 13.3 million

▲ 731% vs 2024

Profit

Caution

€ -3.9 million

▲ 55% vs 2024

Debts

Low

€ 7 million

▲ 40% vs 2024

PanTera from Mol, company number BE0784992591, closed financial year 2025 with a result of € -3.9 million after tax. For that financial year PanTera recorded revenue of € 13.3 million and equity of € 108.8 million. Compared with financial year 2024, the result moved from € -8.6 million to € -3.9 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What happened at PanTera?

What happened at PanTera in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Karen Verwimp stepped down as director. NBB
  • Jean-François Rivassou stepped down as director. NBB
  • Primix Bio Ventures BV stepped down as director. NBB
  • Henri De Romrée de Vichenet stepped down as director. NBB
  • Martijn Kleijwegt stepped down as director. NBB
  • Pascal De Langhe stepped down as director. NBB
  • Catherine Vandenborre stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 3.9 million. Source: NBB ↗

In short

From € 1.1 million loss in 2023 to € 3.9 million loss in 2025.

Paid € 1,290 in corporate taxes since 2023.

Pays suppliers within 155 days on average.

Original PDFs at the National Bank ↗

A new publication or filing at PanTera? We notify you, reason included.

Follow PanTera

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire 35.8%
ION Beam Applications 34.9%
LSP 7 Coöperatief U.A. 13%
Federale Participatie- en Investeringsmaatschappij 4.7%
+6
PanTera

The shares are held by Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire (35.8%), ION Beam Applications (34.9%), LSP 7 Coöperatief U.A. (13%), Federale Participatie- en Investeringsmaatschappij (4.7%), Korys Investments (2.7%) and Eurazeo NovSanté Fund (2.6%).

See the full network in the app

Directors

According to the 2025 annual accounts

Karen Verwimp

Director

since 2024 · until 2030

Jean-François Rivassou

Director

since 2024 · until 2030

Primix Bio Ventures BV

Director · represented by Luc Dochez

Also active at: Vico Therapeutics International

since 2024 · until 2030

Henri De Romrée de Vichenet

Director

since 2024 · until 2030

Soumya Chandramouli

Director

since 2024 · until 2025

Martijn Kleijwegt

Director

since 2024 · until 2030

Thomas Pevenage

Director

since 2025 · until 2025

Pascal De Langhe

Director

since 2024 · until 2030

Catherine Vandenborre

Director

since 2025 · until 2030

Shareholders

Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire

35.8%

ION Beam Applications

34.9%

LSP 7 Coöperatief U.A.

13%

Federale Participatie- en Investeringsmaatschappij

4.7%

Korys Investments

2.7%

Eurazeo NovSanté Fund

2.6%

Kurma Growth Opportunities FPCI

2.6%

Paladin Langfrist GmbH & Co KGAA

2.6%

Wallonie Entreprendre

0.7%

Participatiemaatschappij Vlaanderen

0.7%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Boeretang 192

2400 Mol

2.338.498.467

Boeretang 200

2400 Mol

Active since 20 April 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

PanTera website
HTTPS pantera-life.com
 About

Technologies

AWS S3Font AwesomeGoogle AnalyticsNginxPHPWordPressYoast SEOjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

AMAZON-02 - Amazon.com, Inc., US

Domain

Domain

pantera-life.com

Registered

2022-06-28

Registrar

EuroDNS S.A.

Expires

2026-06-28

Website info

HTTPS Ja
Languages EN
Copyright 2026

Features

Webshop Blog Jobs Contact page

Security

✓ HTTPS
✓ SPF
✗ DMARC

Details

Company number
0784.992.591
VAT number
BE 0784.992.591
Registered office
Boeretang 192, 2400 Mol
Names & denominations
PanTera
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
20 April 2022
Peppol
Active · Active since 24 Jun 2025
Contact
pantera-life.com
Activities · NACE

Vervaardiging van overige farmaceutische producten

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of PanTera?
The enterprise number of PanTera is BE0784992591.
What is the address of PanTera?
The registered office of PanTera is located at Boeretang 192, 2400 Mol.
When was PanTera founded?
PanTera was founded on 20 April 2022.
What is the main activity of PanTera?
The main activity of PanTera is "Vervaardiging van overige farmaceutische producten" (NACE code 21209).
Does PanTera have a website?
Yes, PanTera has a website at pantera-life.com.
Does PanTera have an online shop?
Yes, PanTera has an online shop.
Is PanTera active on social media?
Yes, PanTera is active on Facebook, Linkedin.
How much profit did PanTera make in 2025?
PanTera recorded a loss after taxes of € 3,906,435 in financial year 2025.
What is the revenue of PanTera?
In its most recent annual accounts (2025), PanTera reported revenue of € 13,277,221.
How many employees does PanTera have?
According to the 2025 annual accounts, PanTera has 24.2 full-time equivalents (FTE).
Where can I find the annual accounts of PanTera?
PanTera files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of PanTera?
According to the 2025 annual accounts, the directors of PanTera are: Karen Verwimp, Jean-François Rivassou, Primix Bio Ventures BV, Henri De Romrée de Vichenet, Soumya Chandramouli, Martijn Kleijwegt, Thomas Pevenage, Pascal De Langhe.
Who owns PanTera?
The shares are held by Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire (35.8%), ION Beam Applications (34.9%), LSP 7 Coöperatief U.A. (13%), Federale Participatie- en Investeringsmaatschappij (4.7%), Korys Investments (2.7%) and Eurazeo NovSanté Fund (2.6%).
Who are the shareholders of PanTera?
According to the 2025 annual accounts, the shareholders of PanTera are: Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire (35.8%), ION Beam Applications (34.9%), LSP 7 Coöperatief U.A. (13%), Federale Participatie- en Investeringsmaatschappij (4.7%), Korys Investments (2.7%), Eurazeo NovSanté Fund (2.6%), Kurma Growth Opportunities FPCI (2.6%), Paladin Langfrist GmbH & Co KGAA (2.6%), Wallonie Entreprendre (0.7%), Participatiemaatschappij Vlaanderen (0.7%).